![](https://i-invdn-com.investing.com/news/LYNXNPEB6J0AJ_L.jpg)
Earnings call: Rigel Pharmaceuticals reports robust sales growth in Q2
Rigel (NASDAQ:RIGL) Pharmaceuticals, Inc. (NASDAQ: RIGL) has released its financial results for the second quarter of 2024, highlighting significant sales growth and the successful commercial launch of GAVRETO, its newly approved therapy for certain types …